Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.64 |
| ▸ | CES2 | O00748 | 1/20 | 0.64 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | FNTA | P49354 | 1/20 | 0.52 |
| ▸ | FNTB | P49356 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6363616 | 0.97 | CES1 (0.61) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL9111034 | 0.97 | CES1 (0.61) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL3966085 | 0.90 | AKR1B1 (0.65) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL77563 | 0.89 | CES1 (0.70) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL7503862 | 0.89 | CES2 (0.52) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL9693670 | 0.86 | CES1 (0.67) | CES1CES2AKR1B1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL27690655 | 0.86 | CES1 (0.67) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL5217028 | 0.86 | CES1 (0.54) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL9079361 | 0.86 | CES1 (0.54) | CES1CES2AKR1B1MEN1KMT2A | |
| SCHEMBL8860009 | 0.86 | CES1 (0.54) | CES1CES2AKR1B1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2197829-B1 | ARYLAMINE SYNTHESIS METHOD | CENTRE NAT RECH SCIENT (FR) | 2016-05-04 | — | — | EP | claimed |
| US-8399680-B2 | Arylamine synthesis method | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2013-03-19 | — | — | US | claimed |
| US-20100298571-A1 | ARYLAMINE SYNTHESIS METHOD | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2010-11-25 | — | — | US | claimed |
| EP-1363923-B1 | RHODIUM AND IRIDIUM COMPLEXES | MERCK PATENT GMBH (DE) | 2009-04-01 | — | — | EP | claimed |
| EP-1562964-B1 | PALLADIUM AND PLATINUM COMPLEXES | MERCK PATENT GMBH (DE) | 2006-07-19 | — | — | EP | claimed |
| US-20040138455-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2004-07-15 | — | — | US | claimed |
| EP-0912467-B1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE SA (FR) | 2002-04-24 | — | — | EP | claimed |
| US-4116869-A | POLYMERIZATION | PHILLIPS PETROLEUM COMPANY (US) | 1978-09-26 | — | — | US | claimed |
| US-4095017-A | VINYL MONOMER POLYMERIZATION OR COPOLYMERIZATION CATALYZED BY ORGANOALUMINUM-ORGANOPHOSPHINE-METAL SALT OF A BETA-DIKETONE CATALYST SYSTEM | PHILLIPS PETROLEUM COMPANY (US) | 1978-06-13 | — | — | US | claimed |
| US-4020018-A | Alkene oxide or acrylate polymerization or copolymerization catalyzed by organoaluminum-organophosphine-metal salt of a beta-diketone | PHILLIPS PETROLEUM COMPANY (US) | 1977-04-26 | — | — | US | claimed |
| US-3989741-A | ALKYLATION, REDUCTION, TRANSESTERIFICATION, ESTER-SUBSTITUTED PHENOLS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-11-02 | — | — | US | claimed |
| US-12635401-B2 | Metal complexes | UDC Ireland (IE) | 2026-05-19 | — | — | US | disclosed |
| US-20260070936-A1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2026-03-12 | — | — | US | disclosed |
| EP-4069709-B1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2025-04-23 | — | — | EP | disclosed |
| US-12250871-B2 | Metal complexes | UDC IRELAND LIMITED (IE) | 2025-03-11 | — | — | US | disclosed |
| US-4036605-A | CATALYZING OXIDATION OF HYDROCARBONS WITH A B-KETOENOLATE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1977-07-19 | — | — | US | disclosed |
| US-4029713-A | ANTIOXIDANTS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-06-14 | — | — | US | disclosed |
| US-4020018-A | Alkene oxide or acrylate polymerization or copolymerization catalyzed by organoaluminum-organophosphine-metal salt of a beta-diketone | PHILLIPS PETROLEUM COMPANY (US) | 1977-04-26 | — | — | US | disclosed |
| US-3989741-A | ALKYLATION, REDUCTION, TRANSESTERIFICATION, ESTER-SUBSTITUTED PHENOLS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-11-02 | — | — | US | disclosed |
| US-3935316-A | Method of use and formulations | THE UPJOHN COMPANY (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070936-A1 | METAL COMPLEXES | SCO2, CBR1, CORO1C | CES1 2189/4885CES2 1956/4885AKR1B1 934/4885 |
| US-12635401-B2 | Metal complexes | SCO2, SOD1, NR4A1 | CES1 4058/4885CES2 2075/4885AKR1B1 2502/4885 |
| US-20040138455-A1 | Rhodium and iridium complexes | RPIA, MPI, INPP5B | CES1 4725/4885CES2 3866/4885AKR1B1 3843/4885 |
| US-12250871-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | CES1 4808/4885CES2 3040/4885AKR1B1 4654/4885 |
| US-20100298571-A1 | ARYLAMINE SYNTHESIS METHOD | NAT1, ASNS, AOC2 | CES1 1684/4885CES2 369/4885AKR1B1 484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.